Latest 8-K filings

Boxlight Corporation's Series D preferred stockholders have consented to and ratified the issuance of Series E preferred stock, while also agreeing to certain waivers and conversion/registration limitations.

Victory Capital Holdings, Inc. announced its September 30, 2026, Assets Under Management (AUM) figures, reporting $351.9 billion and third-quarter long-term net inflows of $11.7 billion.

Citigroup Inc. announced its third quarter 2026 results, showcasing the best third-quarter revenue in a decade with significant improvements in returns.

The Procter & Gamble Company announced a quarterly dividend of $1.0885 per share and confirmed the election of all 12 director nominees at its Annual Meeting of Shareholders.

Avalon Holdings Corporation has amended its existing credit agreement, extending the maturity date of its line of credit by one year.

Cavitation Technologies, Inc. and Alchemy Beverages Inc. have entered into definitive tender offer agreements with BrightFlixx Finance (Luxembourg) S.A. for an aggregate of $42 million in cash.

JPMorgan Chase & Co. announced robust third-quarter 2026 financial results, showcasing significant year-over-year growth in net income and revenue, alongside solid capital and liquidity positions.

Crexendo, Inc. has released an investor presentation on its website, providing information to stakeholders.

Alaunos Therapeutics completes acquisition of Velaris Therapeutics and closes an oversubscribed $350 million private placement to advance a pipeline of pulmonary hypertension therapies.

SkyAI intends to launch a cash tender offer to repurchase up to 95% of its outstanding shares and warrants at $3.00 per share, while also rejecting an unsolicited acquisition proposal from Forward Industries.

SSR Mining Inc. has entered into a definitive agreement to acquire Roxmore Resources Inc. for C$6.75 per share in cash, plus a stake in a newly formed exploration company, enhancing its US gold production platform.

SS Innovations International, Inc. announced the submission of its response to the FDA's request for additional information regarding its SSi Mantra surgical robotic system's 510(k) application.

bioAffinity Technologies announced it will present new data at CHEST 2026 on its investigational sputum-based tests for characterizing lung inflammation and detecting protein biomarkers related to asthma and COPD.

Dream Finders Homes, Inc. has increased its revolving credit facility commitments by $220 million, bringing the total to approximately $1.7 billion.

MindWave Innovations Inc. USA has signed a two-year agreement with BlockAssure Inc. to build and operate AssureChain, a dedicated blockchain network for insurance and reinsurance operations.

Bluejay Diagnostics announced the completion of a manufacturing site establishment for its Symphony cartridges, a key contractual milestone with Toray Industries, ahead of schedule.

Trasteel Group announced robust first-half 2026 financial results, with revenues up 40% year-over-year, and provided updated full-year projections, while advancing strategic initiatives including the La Magona plant takeover and a joint venture in the MENA region.

Oncotelic Therapeutics presented its PDAOAI platform and hepatocellular carcinoma research at Drug Discovery 2026, highlighting a new initiative for research collaborations.

Commercial Metals Company announced its board has declared a regular quarterly cash dividend of $0.20 per share, payable November 11, 2026.

Capstone Holding Corp. has successfully completed its planned redomicile from Delaware to Nevada through a merger with its wholly-owned subsidiary, Capstone Holding Corp. (Nevada).

Bumble Inc. has entered into a definitive agreement to be acquired by Ithaca Holdings in an all-cash transaction valued at $1.3 billion, offering shareholders $6.05 per share.

Danaher Corporation announced the appointment of two new directors to its Board and the waiver of Founder Restricted Stock Units by its co-founders.

DeFi Development Corp. announced a significant increase in its SOL holdings and highlighted the record performance of its preferred stock (CHAD) amidst a cryptocurrency selloff.

Workday, Inc. announced its definitive agreement to acquire C1.ai, a leading agentic identity platform, to enhance its capabilities in managing access for both human employees and AI agents.

Bitmine Immersion Technologies announces a substantial increase in its Ethereum holdings, reaching 6.03 million tokens, contributing to a total crypto, cash, and marketable securities portfolio valued at $16.2 billion.

Phio Pharmaceuticals announced the successful completion of its first commercial-scale cGMP batch of PH-762 drug substance, a critical step supporting the planned Phase 2b clinical trial in Q1 2027.

Ondas Inc. and Palantir Technologies Inc. have announced the formation of Regna AI, a new company focused on providing sovereign AI solutions for defense and government applications.

CervoMed announced initial Phase 2a trial data showing a reduction in a key neurodegeneration biomarker, neurofilament light (NfL), over 12 weeks of treatment with neflamapimod in patients with nonfluent variant primary progressive aphasia (nfvPPA).

SAB Biotherapeutics announced its investigational immunotherapy SAB-142 has received FDA Fast Track designation for treating new-onset Stage 3 type 1 diabetes.

MetaVia Inc. announced the appointment of Sarah Kaplan Browne, M.D., as its new Chief Medical Officer, effective October 12, 2026, bringing over 20 years of clinical development experience.